Next™ CAR-T Discovery

Cellular therapyCAR-T therapy is emerging as one of the most promising cancer therapeutics, with this in mind, Creative Biolabs developed a comprehensive set of integrated services including CAR-T discovery, CAR-T engineering, CAR-T in vitro validation, CAR-T in vivo animal testing, CAR-T manufacturing. We have ample expertise and talented team to guide our clients, every step of the way, with the aim to accelerate and promote the progression of your CGT product.

Providing Flexible, Responsive, and Customized Services

Creative Biolabs supports the discovery of cellular and gene therapies via a consultative-based and strategic approach with great expertise and scientific knowledge, plus regulatory concerns. Both individual studies and integrated programs are designed covering all aspects of cellular and gene therapies, such as TCR-T cell therapy, CAR-T cell therapy, CAR-NK cell therapy, CAR-MA cell therapy and OV cell therapy. Our discovery services are provided to primarily mitigate risk factors inherent in discovery and development of the therapeutic types. Our multidisciplinary team will accommodate the specific properties of your CGT product to design an appropriate candidate for our clients. With extensive experience and a proven ability to navigate updated regulatory landscape, our scientists design and manage a series of discovery services that reduce risk and accelerate timelines.

Features:

With access to the biologics’ most comprehensive portfolios (from early discovery to market support), Creative Biolabs is uniquely qualified to speed your journey through drug discovery and development.

We Value Every Partner, Every Project, as if It Were Our Own.

We provide the following modules of cellular and gene therapy discovery services, but not limited to these. If you are interested in any other specific requirements, please feel free to contact us to tailor a specific service for you. For current in-house services, please visit the following modules.

T Cell Receptor (TCR) T Cell Therapy

Offer an end-to-end integrated solution to cover all your needs for TCR-T product discovery and development. Both αβ T cell and γδ T cell derived from patients and normal populations can be achieved...

Chimeric Antigen Receptor (CAR) T Cell Therapy

Offer an end-to-end integrated CAR-T solution covering all steps prior to clinical trials. You can start at any module and request a flexible integration of different modules to fit your projects...

Chimeric Antigen Receptor (CAR) NK Cell Therapy

Offer a unique and professional platform for NK cell therapy covering all services and integrated solutions. We are committed to getting access to the most complete solution to develop your product...

Chimeric Antigen Receptor (CAR) Macrophage Cell Therapy

Offer innovative and proprietary platform for CAR-MA cell therapies with great therapeutic potential for solid tumors...
 

T Cell Receptor Identification

Provide T cell receptor library analysis services including deep identification of T cell receptors in human, mouse, rat or rabbit. Analytical results will be delivered in tabular and graphical form...

MHC-ligandome Mapping

Offer MHC-ligandome mapping services, the higher resolution and sensitivity of LC-MS / MS technologies, and optimized acquisition methods to map tumor immunopeptides...

TCR Generation and Optimization

Offer genetic engineering techniques to insert different functional TCR-encoding genes into T cells, making them specifically reactive to tumors, as well as TCR affinity and avidity optimization...

Neoantigen Identification

Offer a unique and comprehensive sequencing portfolio that combines proprietary information algorithms and computational workflows to drive discovery of neoantigens...

scFv Generation and Optimization

Combine our highly trusted hybridoma technology with our top antibody sequencing and recombinant antibody expression platforms to generate highly specific scFvs to meet our clients’ needs...

Highlights

Under the complexities of scientific and technical challenges, cellular and gene therapy programs should be highly customized and vary greatly as per the product attributes. To move the CGT programs through regulatory approval faster, Creative Biolabs is the trusted and reliable partner who provides access to a deep scientific network and integrates different components of the services to achieve your desired milestones and push the program to market on time. Any questions, please contact us to learn more.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Services
Copyright © 2024 Creative Biolabs. All Rights Reserved.